Skip to main content

For each disease registered for assessment, complete:

  • The HLA type(s)/allele(s) of interest relevant to the disease e.g. DQB1*03:02, A*29.  Please also use this field to define the limitation of your detection capabilities if you are using a commercial kit.
  • The HLA type for assessment, as reported clinically.  If you are using a commercial kit and believe there is an antigen present not defined by your kit then please indicate this using ‘XX’, e.g. DQB1*03:03 – DQA1*03 – DRB1*XX
  • Interpretative comments, as reported clinically (optional, not assessed)
  • Participants should report the loci and at the resolution they test and report clinically.

Participants are requested to report results using the correct nomenclature

Technical issues/invalid results (e.g. control failures, quality issues) should be reported as ‘NT’ (Not tested). Reasons for not testing need to be reported on the final result entry page. ‘Not tested’ results will not be assessed.

For any queries with reporting contact